Hitoshi Ojima

5PUBLICATIONS
29CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersSoftware and application security
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 26, 2024
Oxaliplatin Added to Fluoropyrimidine/Bevacizumab as Initial Therapy for Unresectable Metastatic Colorectal Cancer in Older Patients: A Multicenter, Randomized, Open-Label Phase III Trial (JCOG1018).

Atsuo Takashima, Tetsuya Hamaguchi, Junki Mizusawa

|Jan 09, 2024
Exploratory Biomarker Analysis Using Plasma Angiogenesis-Related Factors and Cell-Free DNA in the TRUSTY Study: A Randomized, Phase II/III Study of Trifluridine/Tipiracil Plus Bevacizumab as Second-Line Treatment for Metastatic Colorectal Cancer.

Yu Sunakawa, Yasutoshi Kuboki, Jun Watanabe

|Nov 01, 2023
The Feasibility and Reliability of Upper Arm-Worn Apple Watch Heart Rate Monitoring for Surgeons During Surgery: Observational Study.

Kazunosuke Yamada, Yasuaki Enokida, Ryuji Kato

|Mar 04, 2023
Trifluridine/tipiracil+bevacizumab (BEV) vs. fluoropyrimidine-irinotecan+BEV as second-line therapy for metastatic colorectal cancer: a randomised noninferiority trial.

Yasutoshi Kuboki, Tetsuji Terazawa, Toshiki Masuishi

|Nov 26, 2022
Robotic surgery for simultaneous gastric and rectal cancers.

Hitoshi Ojima, Kazunosuke Yamada, Takahiro Takada

Pageof 1

Frequent Collaborators

2 joint publications

Yasutoshi Kuboki

2 joint publications

Toshiki Masuishi

2 joint publications

Hisato Kawakami

2 joint publications

Atsuo Takashima